Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2016; 6(12): 047-055


Development and validation of a new RP-HPLC method for the estimation of dutasteride in bulk and pharmaceutical formulations

Poonguzhali Subramanian, P. S. Rajinikanth.




Abstract

A simple, specific, accurate and stability indicating reversed phase high performance liquid chromatographic method was developed for the simultaneous determination of dutasteride in pharmaceutical formulations and bulk drugs using C-18 column (150 mm × 4.6 mm, 5.0 μm). The mobile phase composed of methanol: phosphate buffer saline (PBS) (80:20, v/v), pH 6.8 adjusted with O-phosphoric acid and the flow rate was maintained at 1ml/min at 30°C temperature. The retention time of dutasteride was found to be 4.1 min. Linearity was established in the range of 1-15 μg/ml with a coefficient correlation of 0.999 and the eluents were monitored at 230 nm. The percentage recoveries were found to be in the range of 99.06-100.60%. The developed method was validated as per International Conference on Harmonization (ICH) guidelines with respect to limit of detection, limit of quantification, precision, accuracy, Linearity and system suitability. This method can be successfully employed for simultaneous quantitative analysis of dutasteride in pharmaceutical formulations and bulk drugs as well.

Key words: Keywords: Dutasteride, Method development, RP-HPLC, validation






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.